On December 27, Fosun Health in the mainland announced that the online platform opened the registration of vaccination intentions for the bivalent vaccine of Fubitai in Hong Kong.
Fubitai Bivalent Vaccine Appointment Registration Entrance.
Fosun Health said that from now on, users can log in to the Fosun Health platform or WeChat applet, find the "New Crown Vaccine" entry on the homepage, and register their intention to vaccinate the Fubitai bivalent vaccine in Hong Kong. After officially resuming customs clearance, go to Hong Kong to receive Fubitai bivalent vaccine at your own expense.
On March 16, 2020, Fosun Pharma and Germany's BioNTech announced that they had reached a strategic cooperation in the development of mRNA vaccines. Fosun Pharma was authorized by BioNTech to develop and commercialize exclusively in China, Hong Kong, Macao and Taiwan based on its proprietary mRNA technology platform The new crown vaccine developed.
In December 2022, the mRNA COVID-19 vaccine Fubita BNT162b2 and Fubita bivalent vaccine were officially registered in Hong Kong.
Beijing citizens scramble to apply for travel documents such as Hong Kong and Macau travel permits. Spring Festival or retaliatory tourist crowds. Searches for outbound travel soar. Hong Kong is the second most popular tourist destination